
Endogenous Glycoprotein,
MISSION CRITICAL: For in vitro laboratory research only. Not for human or veterinary use. Not evaluated by the FDA. Must be 21+.
Follistatin is a endogenous glycoprotein, activin-binding protein, and myostatin inhibitor. With the molecular formula Glycoprotein and a molecular weight of ~34 kDa (CAS: 117628-82-7), it is characterized in foundational biochemical research.
Published research demonstrates Follistatin modulates targeted signaling cascades within cell tissue models (PMID: 41423190).
In cellular environments, Follistatin exhibits selective binding and corresponding pathway activation (PMID: 39585121).
Suh et al. (2025) investigated Follistatin's binding affinity and receptor interactions in vitro (PMID: 41423190).
Suh J, et al. (2025). Myostatin Function during In Vitro Myogenesis: Considerations for Knockout-Based Mechanistic Analysis. J Bone Metab.PMID: 39585121Alonso-Puyo et al. (2024) investigated Follistatin's binding affinity and receptor interactions in vitro (PMID: 39585121).
Alonso-Puyo J, et al. (2024). The Non-Linear Profile of Aging: U-Shaped Expression of Myostatin, Follistatin and Intermediate Signals in a Longitudinal In Vitro Murine Cell Sarcopenia Model. Proteomes.